ID: ALA5084806

Max Phase: Preclinical

Molecular Formula: C17H21Cl2NO2

Molecular Weight: 342.27

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CCCCCCCN(O)C(=O)/C=C/c1ccc(Cl)cc1Cl

Standard InChI:  InChI=1S/C17H21Cl2NO2/c1-2-3-4-5-6-7-12-20(22)17(21)11-9-14-8-10-15(18)13-16(14)19/h2,8-11,13,22H,1,3-7,12H2/b11-9+

Standard InChI Key:  MCMVPFBPJNUJIF-PKNBQFBNSA-N

Associated Targets(non-human)

Botulinum neurotoxin type A 1303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 342.27Molecular Weight (Monoisotopic): 341.0949AlogP: 5.36#Rotatable Bonds: 9
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.78CX Basic pKa: CX LogP: 5.56CX LogD: 5.54
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.22Np Likeness Score: -0.16

References

1. Patel EN, Turner LD, Hixon MS, Janda KD..  (2022)  Identification of Slow-Binding Inhibitors of the BoNT/A Protease.,  13  (4.0): [PMID:35450355] [10.1021/acsmedchemlett.2c00028]

Source